Welcome to our dedicated page for Acadia Healthcar news (Ticker: ACHC), a resource for investors and traders seeking the latest updates and insights on Acadia Healthcar stock.
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a behavioral healthcare company that operates a large network of inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, comprehensive treatment centers and outpatient clinics across the United States and Puerto Rico. This news page aggregates company-specific updates and disclosures that help investors and observers follow developments in Acadia’s behavioral healthcare operations and corporate activities.
News related to ACHC often includes quarterly earnings releases, updates to financial guidance, and details on revenue performance by service type, such as acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers and residential treatment centers. The company also issues news about capital expenditure plans, bed additions, and development activity, including the opening of new hospitals, expansions of existing facilities and the addition of new comprehensive treatment centers.
Acadia’s news flow features announcements about participation in healthcare and investor conferences hosted by firms such as J.P. Morgan, UBS and Jefferies, where members of senior management discuss strategy, capital allocation and operating performance. Press releases may also cover executive leadership changes, including appointments and transitions in key roles like the Chief Financial Officer and Chief Operating Officer, as well as statements from the company regarding its approach to shareholder value and governance.
Other notable news items can include updates on professional and general liability reserves, securities litigation settlements, and responses to public letters from shareholders who comment on strategy and governance. By reviewing the ACHC news feed on this page, users can monitor Acadia’s reported operating trends, strategic priorities, capital plans and governance developments over time.
Acadia Healthcare (NASDAQ: ACHC) will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, January 12-15, 2026. The company’s presentation is scheduled for Tuesday, January 13, 2026 at 5:15 p.m. PT / 7:15 p.m. CT and will be webcast live on Acadia’s investor website.
A replay will be available on the company website for 30 days following the presentation. Investors can access the live webcast via the Investors section at www.acadiahealthcare.com.
Acadia Healthcare (NASDAQ: ACHC) updated its professional and general liability (PLGL) reserves after a third-party actuarial review, lowering 2025 guidance. The company now expects 2025 Adjusted EBITDA $601M–$611M (previously $650M–$660M) and Adjusted EPS $1.94–$2.04 (previously $2.35–$2.45), a reduction of $49M to EBITDA and $0.41 to EPS driven entirely by higher PLGL costs.
Key PLGL figures: projected 2025 PLGL expense ~$116M vs $54M in 2024 (+$62M); 168% increase in 2025 policy-year claim frequency; year-end 2025 net PLGL liability expected to be $145M–$165M (vs $78M at 12/31/2024); 2026 PLGL expense forecasted at $100M–$110M.
Acadia Healthcare (NASDAQ: ACHC) will participate in a fireside chat at the UBS Global Healthcare Conference in Palm Beach Gardens, Florida, running November 9–12, 2025.
The company’s presentation will be webcast live on Tuesday, November 11, 2025 at 1:45 p.m. Central / 2:45 p.m. Eastern and will be accessible via the Investors section of the company website. A replay will be available on the website for 30 days following the event.
Acadia Healthcare (NASDAQ: ACHC) reported Q3 2025 revenue of $851.6M, up 4.4% year-over-year, with same-facility revenue +3.7% and same-facility admissions +3.3%.
Adjusted EBITDA was $173.0Mrevenue $3.28–3.30B, Adjusted EBITDA $650–660M, and adjusted EPS $2.35–2.45.
Acadia added 429 beds in Q3 (908 YTD) and expects 945–1,076 bed additions for 2025. Management changes include CFO Todd Young joining Oct 27 and COO Dr. Nasser Khan resigning effective Nov 3. Cash was $118.7M with $786.7M available on the $1.0B revolver.
Acadia Healthcare (NASDAQ: ACHC) will release third quarter 2025 results on Wednesday, November 5, 2025 after market close. A conference call with institutional investors and analysts is scheduled for 9:00 a.m. ET on Thursday, November 6, 2025.
A live webcast will be available in the Investors section at www.acadiahealthcare.com and the webcast replay will remain accessible for 30 days.
Acadia (NASDAQ: ACHC) appointed Todd Young as Chief Financial Officer, effective October 27, 2025. Young brings roughly 25 years of financial and healthcare experience, most recently serving as CFO at Elanco where he helped build the finance organization after the company separated from Eli Lilly. He previously served as CFO of ACADIA Pharmaceuticals and holds a bachelor’s in economics and a law degree. Tim Sides, interim CFO since August 2025, will return to Senior Vice President, Operations Finance. Leadership says Young will focus on capital allocation, treasury, operational efficiency, and supporting disciplined growth in behavioral healthcare access and outcomes.
Khrom Capital Management LLC, owning 5.5% of Acadia Healthcare (NASDAQ: ACHC), has sent a critical letter to the company's Board of Directors demanding immediate strategic actions to address severe underperformance. The activist investor highlights ACHC's significant shareholder value destruction, with Total Shareholder Return (TSR) showing concerning metrics: -71.1% (1-year) and -70.7% (10-year).
The letter criticizes multiple strategic missteps, including the UK market exit, leadership changes, and aggressive capital expenditure amid DOJ investigations. Khrom Capital demands an immediate formal strategic review, including potential company sale, accelerated governance reforms, and Board restructuring, noting that current directors have served up to 20 years while collectively owning only 1.3% of company stock.
Acadia Healthcare (NASDAQ: ACHC) has issued a statement reaffirming its commitment to enhancing long-term shareholder value. The company outlined its strategic focus on disciplined growth in behavioral health and substance use disorder treatment services.
The company's strategy includes expanding access to behavioral healthcare, improving clinical outcomes, and driving operational efficiency across its network. Acadia is also working to optimize its portfolio to enhance cash flow and strengthen its financial position. The company has retained Goldman Sachs and J.P. Morgan as financial advisors and Kirkland & Ellis LLP as legal advisor.
Engine Capital LP, owning approximately 3% of Acadia Healthcare (NASDAQ: ACHC), has sent a critical letter to the company's Board of Directors highlighting significant concerns about the company's performance and management. The activist investor points to negative returns and underperformance compared to other healthcare facility operators.
Engine Capital criticizes several aspects of Acadia's operations, including poor execution, flawed reorganization under CEO Christopher Hunter, increasing costs, inadequate capital allocation, and insufficient board oversight. The investor demands immediate actions, including halting growth capital projects, improving operations and cost structure, considering asset sales, and implementing share repurchases.
Acadia Healthcare (NASDAQ: ACHC) announced its participation in the upcoming Jefferies 2025 Healthcare Services Conference, scheduled for September 29-30, 2025, in Nashville, Tennessee. The company will participate in a fireside chat, which will be available via webcast starting at 9:35 AM ET on September 29, 2025.
Investors can access the live presentation through the "Investors" section of Acadia's website. A replay will remain available for 30 days following the event.
FAQ
What is the current stock price of Acadia Healthcar (ACHC)?
What is the market cap of Acadia Healthcar (ACHC)?
